Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Transfusion. 2021 May;61(5):1525-1532. doi: 10.1111/trf.16356. Epub 2021 Mar 11.
Hematopoietic stem cell transplantation is an important treatment that is dependent on the collection of sufficient CD34+ hematopoietic progenitor cells. The peripheral blood CD34 count (PB CD34+ counts) measured by flow cytometry can be used in predicting CD34+ stem cell yields hours before the completion of collection. Previously described formulas to predict the yield have used many different variables. As such, there is currently no consensus on an industry-standard algorithm or formula.
Retrospective reviews of same-day PB CD34+ counts and the ensuing absolute CD34+ yields of mobilized donors (allogeneic and autologous) were used to develop and validate a formula using regression analysis to predict the CD34+ stem cell yield. A metric of prediction correlation, using root mean square error (RMSE), was used to assess the robustness of our prediction formula in addition to comparisons with two other published formulas, as well as subset analysis.
A formula in the form of y = mx with r = 0.95 and 95% confidence intervals was generated and validated. The ratio of actual to predicted yield demonstrated a high correlation coefficient (r = 0.96) with linear regression and overall RMSE of 228.4, which was lower than the two prior studies (calculated RMSE = 330.8 and 405.2). Subset analyses indicated male patients, lymphoma patients, and patients >60 years of age demonstrated lower RMSEs.
We have demonstrated a simple yet robust formula that can be used prospectively to accurately predict the CD34+ stem cell yield in both autologous and allogeneic donors, which also accounts for recipient weight.
造血干细胞移植是一种重要的治疗方法,依赖于采集足够的 CD34+造血祖细胞。通过流式细胞术测量外周血 CD34 计数(PB CD34+计数),可在采集完成前数小时预测 CD34+干细胞产量。以前描述的预测产量的公式使用了许多不同的变量。因此,目前尚无行业标准算法或公式的共识。
对同日 PB CD34+计数和随后动员供者(异体和自体)的绝对 CD34+产量进行回顾性分析,以开发和验证一种使用回归分析预测 CD34+干细胞产量的公式。使用均方根误差(RMSE)作为预测相关性的度量标准,评估我们的预测公式的稳健性,除了与另外两个已发表的公式进行比较外,还进行了子集分析。
生成并验证了一种形式为 y = mx 的公式,r 值为 0.95,置信区间为 95%。实际产量与预测产量的比值表现出较高的相关系数(r = 0.96),具有线性回归,总 RMSE 为 228.4,低于前两项研究(计算 RMSE = 330.8 和 405.2)。子集分析表明,男性患者、淋巴瘤患者和>60 岁的患者 RMSE 较低。
我们已经证明了一种简单而强大的公式,可用于前瞻性地准确预测自体和异体供者的 CD34+干细胞产量,该公式还考虑了受体体重。